flunarizine has been researched along with Sleep-Wake-Disorders* in 3 studies
3 other study(ies) available for flunarizine and Sleep-Wake-Disorders
| Article | Year |
|---|---|
Exploding head syndrome: report of two new cases.
Topics: Aged; Anticonvulsants; Flunarizine; Humans; Male; Middle Aged; Migraine without Aura; Noise; Sensation Disorders; Sleep Wake Disorders; Syndrome | 2008 |
The hypnic headache syndrome: report of three new cases.
Three new cases compatible with hypnic headache syndrome (HHS) are presented. The patients were 70, 77, and 79 years of age (2F, 1M). They described a history of nocturnal headache ranging from 5 months to 7 years. One patient was afflicted with diffuse pain but the other two had unilateral pain. In one patient headache was clearly related with dreams, but in the other two this point could not be confirmed. Except for headache being unilateral in two cases, the remaining HHS criteria were present. It is noteworthy that pain responded to flunarizine in two patients. Topics: Aged; Calcium Channel Blockers; Dominance, Cerebral; Dopamine Antagonists; Dreams; Female; Flunarizine; Headache; Humans; Male; Sleep Wake Disorders; Syndrome; Treatment Outcome | 1998 |
Benign familial nocturnal alternating hemiplegia of childhood.
In infancy, two brothers developed recurrent attacks of alternating or bilateral hemiplegia arising exclusively out of sleep. The episodes were terminated by even brief sleep. Neither child had hypotonia, dystonic attacks, paroxysmal eye movement abnormalities, or other features characteristic of the now-classic form of alternating hemiplegia of childhood (AHC). The development of the brothers has so far remained normal. Both parents have a history of migraine. In the older boy, magnetic resonance spectroscopy (MRS) of muscle showed increased inorganic phosphate similar to what is found in children with AHC. In the younger brother and parents, MRS of muscle was normal. Other investigations were unrevealing. Flunarizine greatly reduced the duration of attacks. This genetically determined disorder represents a specific entity that is probably migraine-related and is easily misdiagnosed as AHC. Because of its benign course, particularly as far as mental development is concerned, it must be distinguished from classic AHC, which has a terrible prognosis. Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Clobazam; Electroencephalography; Female; Flunarizine; Hemiplegia; Humans; Infant; Magnetic Resonance Spectroscopy; Male; Migraine Disorders; Muscle, Skeletal; Phosphates; Recurrence; Sleep Wake Disorders | 1994 |